SEC Form 4 · accession 0001213900-19-003164
OptimizeRx Corp · OPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Febbo
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Feb 25, 2019
Accepted (ET)
Feb 26, 2019 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001448431
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionF1,F2 | $1.07 | Feb 25, 2019 | J | 100,000 | A | Feb 28, 2019 | Feb 28, 2021 | Common Stock | 100,000 | 500,000 | D |
| Restricted Stock GrantF1,F3,F4 | — | Feb 25, 2019 | A | 30,000 | A | — | — | Common Stock | 30,000 | 110,000 | D |
Explanation of responses
- F1Not applicable.
- F2The Issuer and the Reporting Person amended the Reporting Person's employment agreement to vest his options as of February 28, 2019.
- F3Each restricted stock grant represents a contingent right to receive one share of the Issuer's common stock.
- F4The reporting person received a restricted stock grant that may vest on February 1, 2020, subject to achievement of the Issuer's year-end revenue performance goals.